We are happy to participate in the inaugural Global BioInnovation Forum during #JPMWeek. Jan 13, 2026 | Virtual Register: https://t.co/Egk48ZoTX7 $PYPD

$PYPD PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors Read the Full News Release 👉 https://t.co/DL01OVDkTR

Join us tomorrow (Wednesday) at @ROTHCapital's virtual KOL event where internationally recognized colorectal surgeon Steven D. Wexner will discuss the clinical & economic burden of SSIs and the therapeutic potential of D-PLEX₁₀₀. https://t.co/SZHfOSxYHL $PYPD

$PYPD PolyPid Announces Positive FDA Pre-NDA Meeting Minutes for D-PLEX₁₀₀ Supporting NDA Submission Read the Full Press Release 👉 https://t.co/7zs2FhIJZl

On Dec. 10 at 11:30am ET @ROTHCapital will host a #KOL event with @SWexner of @MedStarGUH to discuss the science and business case for D-PLEX100. Dikla Czaczkes Akselbrad and @OriWarshavsky will be available to answer investors' questions. Registration link 👇 $PYPD

$PYPD PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025 Read the Full News Release 👉 https://t.co/SZHfOSxYHL

Thank you to PolyPid for joining us as a 2026 Gold Sponsor, showing their commitment to improving patient outcomes. Learn more about @PolyPidLtd here 👉 https://t.co/0gk0zm9kiN Interested in partnership with the SIS? Learn more👉 https://t.co/1WraUhX1XI

$PYPD PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results Read the Full News Release 👉 https://t.co/gSnnBq2Lqv

We are proud and honored to receive the 2025 Therapeutic Solution of the Year! “By addressing one of surgery's most persistent challenges, D-PLEX₁₀₀ delivers better patient outcomes while reducing provider burden” - Bryan Vaughn, Managing Director, @BioTech_Awards $PYPD

$PYPD - PolyPid to Report Third Quarter 2025 Financial Results and Operational Highlights on November 12, 2025 Read the Full Press Release 👉 https://t.co/V4K4iIoBsN

$PYPD PolyPid to Present Its Positive Phase 3 SHIELD II Topline Results at the 2025 American College of Surgeons Clinical Congress Read the Full News Release 👉 https://t.co/1ORZEcWTuv

$PYPD PolyPid to Present at Lytham Partners Fall 2025 Investor Conference and Participate in 4th Annual ROTH Healthcare Opportunities Conference Read the Full News Release 👉 https://t.co/HOpFwfHbHz

$PYPD PolyPid Successfully Completes Israeli Ministry of Health GMP Inspection, Advancing Towards Commercial Manufacturing Readiness for D-PLEX₁₀₀ Read the Full News Release 👉 https://t.co/Ivf8nlbYQ6

$PYPD PolyPid to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference Read the Full News Release 👉 https://t.co/Vkze5J8lsX

$PYPD PolyPid to Present at the 14th Meeting of the Israel Controlled Release Society Conference Read the Full News Release 👉 https://t.co/a4Budqclj4

$PYPD PolyPid Provides Corporate Update and Reports Second Quarter 2025 Financial Results Read the Full News Release 👉 https://t.co/2ysKJPJYQT

$PYPD PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer Read the Full News Release 👉 https://t.co/PcDbOUhyLr

Running global clinical trials takes more than innovation - it’s about operational excellence, regulatory agility & strong partnerships. PolyPid’s Dalit Hazan shares lessons from our D-PLEX100 journey via @ClinicalLeader1. 🔗 https://t.co/Lb2zBdE7FZ $PYPD

$PYPD PolyPid to Report Second Quarter 2025 Financial Results and Operational Highlights on August 13, 2025 Read the Full News Release 👉 https://t.co/7ErsViZb28

$PYPD: @PolyPidLtd Positive Topline Data From D-PLEX₁₀₀ Trial Contributes to Multiple Subsequent Benefits https://t.co/sXjUf9NniB